Abstract
This paper briefly reports the Milan Cancer Institute experience on Hodgkin’s disease treated with an Adriamycin- and bleomycin-based combination (ABVD: Adriamycin, bleomycin, vinblastine, and dacarbazine). Following the initial publication on MOPP (mustine, oncovin, procarbazine, and prednisone) chemotherapy (De Vita et al. 1970), many investigators including ourselves have attempted to improve further the therapeutic results by modifying the original drug combination. Published findings have indicated that none of the modified MOPP regimens has indeed achieved superior results (Bonadonna and Santoro 1982). In 1974, we developed a four-drug combination (ABVD) whose components were totally different from those included in the MOPP combination. Our aim was to utilize ABVD in MOPP-resistant patients. Through successive randomized studies we have gained experience on the efficacy of ABVD alternated with MOPP and tested versus MOPP within a combined modality treatment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bonadonna G (1982) Chemotherapy strategies to improve the control of Hodgkin’s disease: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 42: 4309–4320
Bonadonna G, Santoro A (1982) Evolution in the treatment strategy of Hodgkin’s disease.Adv Cancer Res 36: 257–293
Bonadonna G, Valagussa P, Santoro A (1986) Alternating non-cross-resistant combination chemotherapy or mechlorethamine, vincristine, procarbazine, and prednisone in stage IV Hodgkin’s disease. A report of 8-year results. Ann Intern Med 104: 739–746
De Vita VT Jr, Serpick AA, Carbone PP (1970) Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med 73: 881–895
De Vita VT, Simon RM, Hubbard SM et al. (1980) Curability of advanced Hodgkin’s disease with chemotherapy. Long term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med 92: 587–595
Gams RA, Omura GA, Velez-Garcia E et al. (1986) Alternating sequential combination chemotherapy in the management of advanced Hodgkin’s disease. A Southeastern Cancer Study Group Trial. Cancer 58: 1963–1968
Goldie JH, Coldman AJ (1985) Genetic instability in the development of drug resistance. Semin Oncol 12: 222–230
Grozea PN, Depersio EJ, Coltman CA et al. (1987) Chemotherapy alone vs. combined modality treatment for stage IIIA Hodgkin’s disease: an eight-year follow-up of a Southwest Oncology Group (SWOG) study No.7518. Proc Third Intl Conference on Malignant Lymphoma, Lugano, Switzerland, p 91
Klimo P, Connors JM (1985) MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin’s disease. J Clin Oncol 3: 1174–1182
Santoro A, Bonadonna G, Valagussa P et al. (1987) Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin’s disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol 5: 27–37
Somers R, Henry-Amar M (1987) MOPP vs alternating MOPP/ABVD in advanced Hodgkin’s disease. Proc Third Intl Conference on Malignant Lymphoma, Lugano, Switzerland, p 32
Vinciguerra V, Propert KJ, Coleman N et al. (1986) Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin’s disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B. J Clin Oncol 4: 838–846
Young RC, Canellos GP, Chabner BA et al. (1978) Patterns of relapse in advanced Hodgkin’s disease treated with combination chemotherapy. Cancer 42: 1001–1007
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Bonadonna, G., Valagussa, P., Santoro, A., Viviani, S., Bonfante, V., Banfi, A. (1989). Hodgkin’s Disease: The Milan Cancer Institute Experience with MOPP and ABVD. In: Diehl, V., Pfreundschuh, M., Loeffler, M. (eds) New Aspects in the Diagnosis and Treatment of Hodgkin’s Disease. Recent Results in Cancer Research, vol 117. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83781-4_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-83781-4_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83783-8
Online ISBN: 978-3-642-83781-4
eBook Packages: Springer Book Archive